Evaluating the relationship between daily self-monitoring of blood glucose and healthcare costs

References

• National Center for Chronic Disease Prevention and Health Promotion. Diabetes Public Health Resource. National Diabetes Fact Sheet. Washington, DC: U.S. Department of Health and Human Services. Available at http://www.cdc.gov/diabetes/pubs/estimat es.htm [accessed 17 February 2004; last updated 4 December 2003].
   Google Scholar
• National Diabetes Statistics. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, 2004. Available at http://diabetes.niddk.nih.gov/dm/pubs/stat istics/ [accessed 4 March 2005; updated December 2004].
   Google Scholar
• Hogan P, Dall T, Nikolov P; American Diabetes Association. Economic costs of diabetes in the US in 2002. Diabetes Care 2003; 26: 917–932.
   PubMed Web of Science ®Google Scholar
• Fox CS, Larson MG, Leip EP et al. Predictors of new-onset kidney disease in a community-based population. Journal of the American Medical Association 2004; 291: 844–850.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Standards of medical care in diabetes—2006. Diabetes Care 2006; 29(Suppl 1): S4–42.
   Google Scholar
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. New England Journal of Medicine 1993; 329: 977–986.
   PubMed Web of Science ®Google Scholar
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352: 837–853.
   Google Scholar
• Standards of medical care in diabetes. Diabetes Care 2004; 27(Suppl 1): S15–S35.
   Google Scholar
• Harris MI. Frequency of blood glucose monitoring in relation to glycemic control in patients with type 2 diabetes. Diabetes Care 2001; 24: 979–982.
   PubMed Web of Science ®Google Scholar
• Rindone JP, Austin M, Luchesi J. Effect of home blood glucose monitoring on the management of patients with non-insulin dependent diabetes mellitus in the primary care setting. American Journal of Managed Care 1997; 3: 1335–1338.
   PubMed Web of Science ®Google Scholar
• Murata GH, Shah JH, Hoffman RM et al. Intensified blood glucose monitoring improves glycemic control in stable, insulin-treated veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES). Diabetes Care 2003; 26: 1759–1763.
   PubMed Web of Science ®Google Scholar
• Evans JM, Newton RW, Ruta DA et al. Frequency of blood glucose monitoring in relation to glycaemic control: observational study with diabetes database. British Medical Journal 1999; 319: 83–86.
   PubMed Web of Science ®Google Scholar
• Martin S, Schneider B, Heinemann L et al. Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study. Diabetologia 2006; 49: 271–278.
   PubMed Web of Science ®Google Scholar
• Fishman PA, Goodman MJ, Hornbrook MC et al. Risk adjustment using automated ambulatory pharmacy data: the RxRisk model. Medical Care 2003; 41: 84–99.
   PubMed Web of Science ®Google Scholar
• Hogan P, Dall T, Nikolov P. Economic costs of diabetes in the US in 2002. Diabetes Care 2003; 26: 917–932.
   PubMed Web of Science ®Google Scholar
• Harris MI, Cowie CC, Howie LJ. Self- monitoring of blood glucose by adults with diabetes in the United States population. Diabetes Care 1993; 16: 1116–1123.
   PubMed Web of Science ®Google Scholar
• Karter AJ, Ferrara A, Darbinian JA et al. Self-monitoring of blood glucose: language and financial barriers in a managed care population with diabetes. Diabetes Care 2000; 23: 477–483.
   PubMed Web of Science ®Google Scholar
• American Academy of Pediatrics. Utah Medicaid Facts; July 2005.
   Google Scholar
• Piette JD, Wagner TH, Potter MB et al. Health insurance status, cost-related medication underuse, and outcomes among diabetes patients in three systems of care. Medical Care 2004; 42: 102–109.
   PubMed Web of Science ®Google Scholar
• Wogen J, Kreilick CA, Livornese RC et al. Patient adherence with amlodipine, lisinopril, or valsartan therapy in a usual- care setting. Journal of Managed Care Pharmacy 2003; 9: 424–429.
   PubMedGoogle Scholar
• Bond GG, Aiken LS, Somerville SC. The health belief model and adolescents with insulin-dependent diabetes mellitus. Health Psychology 1992; 11: 190–198.
   PubMed Web of Science ®Google Scholar
• Levine BS, Anderson BJ, Butler DA et al. Predictors of glycemic control and short- term adverse outcomes in youth with type 1 diabetes. Journal of Pediatrics 2001; 139: 197–203.
   PubMed Web of Science ®Google Scholar
• Carter BL, Kriesel HT, Steinkraus L et al. Antihypertensive drug-prescribing patterns of internists and family physicians. Journal of Family Practice 1989; 29: 257–261.
   Google Scholar
• De Berardis G, Pellegrini F, Franciosi M et al. Quality of care and outcomes in type 2 diabetic patients: a comparison between general practice and diabetes clinics. Diabetes Care 2004; 27: 398–406.
   PubMed Web of Science ®Google Scholar
• Ford ES, Mokdad AH, Giles WH et al. Geographic variation in the prevalence of obesity, diabetes, and obesity-related behaviors. Obesity Research 2005; 13: 118–122.
   PubMedGoogle Scholar
• Harris MI. Racial and ethnic differences in health insurance coverage for adults with diabetes. Diabetes Care 1999; 22: 1679–1682.
   PubMed Web of Science ®Google Scholar
• Palta M, LeCaire T, Daniels K et al. Risk factors for hospitalization in a cohort with type 1 diabetes. Wisconsin Diabetes Registry. American Journal of Epidemiology 1997; 146: 627–636.
   Google Scholar